| scholarly article | Q13442814 |
| P50 | author | Julian Rayner | Q22278468 |
| Rick M. Fairhurst | Q28033929 | ||
| Gavin J. Wright | Q55838269 | ||
| Sumana Sharma | Q56384118 | ||
| P2093 | author name string | Jessica B Hostetler | |
| S Josefin Bartholdson | |||
| P2860 | cites work | Red blood cell invasion by Plasmodium vivax: structural basis for DBP engagement of DARC | Q21131367 |
| Merozoite surface proteins of the malaria parasite: The MSP1 complex and the MSP7 family | Q21147068 | ||
| Duffy negative antigen is no longer a barrier to Plasmodium vivax--molecular evidences from the African West Coast (Angola and Equatorial Guinea) | Q21562260 | ||
| Comparative genomics of the neglected human malaria parasite Plasmodium vivax | Q22122202 | ||
| Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum | Q24297064 | ||
| Large-scale screening for novel low-affinity extracellular protein interactions | Q24316447 | ||
| High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells | Q24548319 | ||
| Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people | Q24600330 | ||
| Plasmodium vivax infection in Anajás, State of Pará: no differential resistance profile among Duffy-negative and Duffy-positive individuals | Q24633012 | ||
| Identification and characterization of a novel Plasmodium falciparum merozoite apical protein involved in erythrocyte binding and invasion | Q27230023 | ||
| A conserved molecular motor drives cell invasion and gliding motility across malaria life cycle stages and other apicomplexan parasites | Q27230081 | ||
| Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC | Q27670749 | ||
| Structural and Functional Basis for Inhibition of Erythrocyte Invasion by Antibodies that Target Plasmodium falciparum EBA-175 | Q27678372 | ||
| Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes | Q27860838 | ||
| Semaphorin-7A is an erythrocyte receptor for P. falciparum merozoite-specific TRAP homolog, MTRAP | Q27972850 | ||
| RON12, a novel Plasmodium-specific rhoptry neck protein important for parasite proliferation | Q27973901 | ||
| Plasmodium falciparum merozoite surface protein 3: oligomerization, self-assembly, and heme complex formation | Q27974527 | ||
| A systems-based analysis of Plasmodium vivax lifecycle transcription from human to mosquito | Q28473572 | ||
| Biochemical and functional analysis of two Plasmodium falciparum blood-stage 6-cys proteins: P12 and P41 | Q28481599 | ||
| Structural analysis of the synthetic Duffy Binding Protein (DBP) antigen DEKnull relevant for Plasmodium vivax malaria vaccine design | Q28544738 | ||
| The neglected burden of Plasmodium vivax malaria | Q29618450 | ||
| Vivax malaria: neglected and not benign | Q29619167 | ||
| Distinct protein classes including novel merozoite surface antigens in Raft-like membranes of Plasmodium falciparum | Q30038991 | ||
| An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparum | Q30043132 | ||
| P-selectin is a host receptor for Plasmodium MSP7 ligands | Q30043222 | ||
| Plasmodium falciparum Pf34, a novel GPI-anchored rhoptry protein found in detergent-resistant microdomains | Q30043644 | ||
| Systematic genetic analysis of the Plasmodium falciparum MSP7-like family reveals differences in protein expression, location, and importance in asexual growth of the blood-stage parasite | Q30044844 | ||
| Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen | Q30049113 | ||
| Construction of a large extracellular protein interaction network and its resolution by spatiotemporal expression profiling | Q30431970 | ||
| A cell surface interaction network of neural leucine-rich repeat receptors | Q30485804 | ||
| Genome Comparison of Human and Non-Human Malaria Parasites Reveals Species Subset-Specific Genes Potentially Linked to Human Disease | Q31044442 | ||
| Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses | Q33333604 | ||
| Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. | Q33350210 | ||
| Three members of the 6-cys protein family of Plasmodium play a role in gamete fertility | Q33553363 | ||
| Naturally acquired antibodies to Plasmodium vivax Duffy binding protein (DBP) in Brazilian Amazon | Q33617528 | ||
| Naturally acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein are short-lived and allele-specific following a single malaria infection | Q47812027 | ||
| Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice | Q47834206 | ||
| Comparative recognition by human IgG antibodies of recombinant proteins representing three asexual erythrocytic stage vaccine candidates of Plasmodium vivax. | Q47835642 | ||
| Plasmodium vivax thrombospondin related adhesion protein: immunogenicity and protective efficacy in rodents and Aotus monkeys | Q47835703 | ||
| Serologic responses to recombinant Plasmodium vivax Duffy binding protein in a Colombian village | Q47838376 | ||
| Codon usage in Plasmodium vivax nuclear genes | Q47847683 | ||
| Age-acquired immunity to a Plasmodium vivax invasion ligand, the duffy binding protein | Q47911026 | ||
| Immunoproteomics profiling of blood stage Plasmodium vivax infection by high-throughput screening assays | Q47957075 | ||
| Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1. | Q48003700 | ||
| Dissection of merozoite surface protein 3, a representative of a family of Plasmodium falciparum surface proteins, reveals an oligomeric and highly elongated molecule | Q48015109 | ||
| Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit | Q48019429 | ||
| Presence of Memory T Cells and Naturally Acquired Antibodies in Plasmodium vivax Malaria-Exposed Individuals Against a Group of Tryptophan-Rich Antigens With Conserved Sequences | Q48023293 | ||
| Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes | Q48028328 | ||
| Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms | Q48036866 | ||
| Further definition of PfEMP-1 DBL-1alpha domains mediating rosetting adhesion of Plasmodium falciparum | Q48124076 | ||
| Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates | Q36539678 | ||
| Heterologous expression of plasmodial proteins for structural studies and functional annotation | Q36938795 | ||
| The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites | Q36945174 | ||
| The C-terminal domain of Plasmodium falciparum merozoite surface protein 3 self-assembles into alpha-helical coiled coil tetramer | Q37188653 | ||
| Plasmodium falciparum merozoite surface protein 2 is unstructured and forms amyloid-like fibrils | Q37270041 | ||
| Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species | Q37506803 | ||
| Host-parasite interactions that guide red blood cell invasion by malaria parasites | Q38376500 | ||
| Antigenicity studies in humans and immunogenicity studies in mice: an MSP1P subdomain as a candidate for malaria vaccine development | Q38943174 | ||
| Characterization of a novel merozoite surface protein of Plasmodium vivax, Pv41. | Q38943184 | ||
| Pv12, a 6-Cys antigen of Plasmodium vivax, is localized to the merozoite rhoptry | Q39175603 | ||
| Profiling the humoral immune responses to Plasmodium vivax infection and identification of candidate immunogenic rhoptry-associated membrane antigen (RAMA). | Q39191809 | ||
| The GPI-anchored 6-Cys protein Pv12 is present in detergent-resistant microdomains of Plasmodium vivax blood stage schizonts | Q39268260 | ||
| Eroding the resistance of Duffy negativity to invasion by Plasmodium vivax? | Q39341327 | ||
| Epitope-specific humoral immunity to Plasmodium vivax Duffy binding protein. | Q39746136 | ||
| Identifying and characterising the Plasmodium falciparum merozoite surface protein 10 Plasmodium vivax homologue. | Q42656009 | ||
| Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection | Q43271064 | ||
| The Plasmodium vivax homologues of merozoite surface proteins 4 and 5 from Plasmodium falciparum are expressed at different locations in the merozoite | Q43919502 | ||
| Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria | Q44164504 | ||
| Immunological responses to a 39.8kDa Plasmodium vivax tryptophan-rich antigen (PvTRAg39.8) among humans | Q44647207 | ||
| Role of the helical structure of the N-terminal region of Plasmodium falciparum merozoite surface protein 2 in fibril formation and membrane interaction | Q44664188 | ||
| Antigenic drift in the ligand domain of Plasmodium vivax duffy binding protein confers resistance to inhibitory antibodies | Q45062896 | ||
| Plasmodium vivax malaria in Duffy-negative individuals from Ethiopia | Q45728740 | ||
| Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli. | Q47664368 | ||
| Baculovirus Merozoite Surface Protein 1 C-Terminal Recombinant Antigens Are Highly Protective in a Natural Primate Model for Human Plasmodium vivax Malaria | Q33752297 | ||
| New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq | Q33808824 | ||
| A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray | Q33859633 | ||
| Prediction of potential GPI-modification sites in proprotein sequences | Q33874951 | ||
| The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites | Q33941679 | ||
| Molecular evidence of Plasmodium vivax mono and mixed malaria parasite infections in Duffy-negative native Cameroonians | Q33988947 | ||
| Identification of proteins from Plasmodium falciparum that are homologous to reticulocyte binding proteins in Plasmodium vivax | Q34006077 | ||
| Serologic markers in relation to parasite exposure history help to estimate transmission dynamics of Plasmodium vivax | Q34091277 | ||
| High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion | Q34129066 | ||
| Avidity-based extracellular interaction screening (AVEXIS) for the scalable detection of low-affinity extracellular receptor-ligand interactions | Q34194654 | ||
| Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis | Q34234390 | ||
| Immunogenicity of a synthetic vaccine based on Plasmodium vivax Duffy binding protein region II. | Q34260750 | ||
| Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian endemic area. | Q34287358 | ||
| Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites | Q34298647 | ||
| Natural human antibody responses to Plasmodium vivax apical membrane antigen 1 under low transmission and unstable malaria conditions in Sri Lanka. | Q34301073 | ||
| The global public health significance of Plasmodium vivax. | Q34314657 | ||
| Plasmodium vivax: clinical spectrum, risk factors and pathogenesis | Q34314662 | ||
| Protective efficacy of a Plasmodium vivax circumsporozoite protein-based vaccine in Aotus nancymaae is associated with antibodies to the repeat region | Q34350954 | ||
| Profiling humoral immune responses to P. falciparum infection with protein microarrays | Q34495128 | ||
| Phase I Safety and Immunogenicity Trial of Plasmodium vivax CS Derived Long Synthetic Peptides Adjuvanted with Montanide ISA 720 or Montanide ISA 51 | Q34546201 | ||
| Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenya. | Q34573683 | ||
| Plasmodium vivax infection among Duffy antigen-negative individuals from the Brazilian Amazon region: an exception? | Q34644273 | ||
| B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax Merozoite Surface Protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon | Q34726966 | ||
| Plasmodium vivax Merozoite Surface Protein-3 (PvMSP3): Expression of an 11 Member Multigene Family in Blood-Stage Parasites | Q34744820 | ||
| A library of functional recombinant cell-surface and secreted P. falciparum merozoite proteins | Q34991300 | ||
| Whole genome sequencing of field isolates reveals a common duplication of the Duffy binding protein gene in Malagasy Plasmodium vivax strains | Q35054176 | ||
| Evaluation of the acquired immune responses to Plasmodium vivax VIR variant antigens in individuals living in malaria-endemic areas of Brazil | Q35113431 | ||
| New antigens for a multicomponent blood-stage malaria vaccine | Q35216634 | ||
| Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens | Q35264640 | ||
| The origin and diversification of the merozoite surface protein 3 (msp3) multi-gene family in Plasmodium vivax and related parasites. | Q35524269 | ||
| Expression and serologic activity of a soluble recombinant Plasmodium vivax Duffy binding protein. | Q35551014 | ||
| Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen | Q35671610 | ||
| New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women | Q36330969 | ||
| Plasmodium vivax: cloning and expression of a major blood-stage surface antigen. | Q36428483 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Plasmodium vivax | Q311376 |
| protein-protein interaction | Q896177 | ||
| merozoite | Q2296434 | ||
| 6-cysteine protein P41 | Q59729268 | ||
| conserved Plasmodium protein, unknown function | Q59736912 | ||
| merozoite surface protein 3 | Q59746966 | ||
| 6-cysteine protein P12 | Q59749776 | ||
| MSP7-like protein | Q59752685 | ||
| P304 | page(s) | e0004264 | |
| P577 | publication date | 2015-12-23 | |
| P1433 | published in | PLoS Neglected Tropical Diseases | Q3359737 |
| P1476 | title | A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions | |
| P478 | volume | 9 |
| Q58118436 | A library of recombinant Babesia microti cell surface and secreted proteins for diagnostics discovery and reverse vaccinology |
| Q30038987 | A novel Pfs38 protein complex on the surface of Plasmodium falciparum blood-stage merozoites |
| Q92735212 | A panel of recombinant proteins from human-infective Plasmodium species for serological surveillance |
| Q48017006 | Advancing Research Models and Technologies to Overcome Biological Barriers to Plasmodium vivax Control |
| Q36018397 | An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection |
| Q33617694 | Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand |
| Q47978995 | Basigin Interacts with Plasmodium vivax Tryptophan-rich Antigen PvTRAg38 as a Second Erythrocyte Receptor to Promote Parasite Growth |
| Q30393258 | Characterization of Pv92, a Novel Merozoite Surface Protein of Plasmodium vivax |
| Q28818385 | Evidence of functional divergence in MSP7 paralogous proteins: a molecular-evolutionary and phylogenetic analysis |
| Q40344561 | Evolution of the merozoite surface protein 7 (msp7) family in Plasmodium vivax and P. falciparum: A comparative approach. |
| Q43923905 | Functional characterization and comparison of Plasmodium falciparum proteins as targets of transmission-blocking antibodies. |
| Q41994105 | Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development |
| Q38938701 | Immunogenicity of glycosylphosphatidylinositol-anchored micronemal antigen in natural Plasmodium vivax exposure |
| Q63045331 | Inhibition of parasite invasion by monoclonal antibody against epidermal growth factor-like domain of Plasmodium vivax merozoite surface protein 1 paralog |
| Q58571278 | Molecular and cellular interactions defining the tropism of Plasmodium vivax for reticulocytes |
| Q37349102 | Plasmodium vivax GPI-anchored micronemal antigen (PvGAMA) binds human erythrocytes independent of Duffy antigen status |
| Q93012608 | Plasmodium vivax Reticulocyte Binding Proteins for invasion into reticulocytes |
| Q30248811 | Recent insights into humoral immunity targeting Plasmodium falciparum and Plasmodium vivax malaria |
| Q56361518 | Self-assembling functional programmable protein array for studying protein-protein interactions in malaria parasites |
| Q56889337 | Serological diagnosis of Mycoplasma pneumoniae infection by using the mimic epitopes |
| Q38839845 | Strategies for new and improved vaccines against ticks and tick-borne diseases |
| Q65937995 | Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody |
| Q60302156 | The Pk41 surface protein diversity, natural selection, sub population and geographical clustering: a 6-cysteine protein family member |
| Q38789240 | The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle |
Search more.